This quarter, Paulson's US long portfolio decreased ~6% from $9.84B to $9.23B. There are 94 13F securities in the portfolio, although only 31 of them are significantly large equity holdings (more than 0.5% of the US long portfolio). The article is focused on the larger holdings. The top five positions are Allergan plc, Shire plc, Mylan NV, Teva Pharmaceuticals, and the SPDR Gold ETF. They together account for ~44% of the entire portfolio. The largest holding is Allergan plc at 10.25% of the portfolio.